Digestive & Intestinal Remedies (Pharmacies) - Tunisia

  • Tunisia
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$21.31m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.66%, resulting in a market volume of US$24.30m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$1.70 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Tunisia has been experiencing steady growth in recent years.

Customer preferences:
Tunisian consumers have shown a growing preference for digestive and intestinal remedies, leading to an increase in demand for these products. This can be attributed to several factors. Firstly, there is a growing awareness among consumers about the importance of digestive health and the impact it has on overall well-being. As a result, people are more inclined to seek remedies to alleviate digestive issues such as indigestion, bloating, and heartburn. Additionally, the increasing adoption of Western dietary habits, including the consumption of processed foods, has led to a rise in digestive problems among the population.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies market in Tunisia is the shift towards natural and herbal remedies. Consumers are becoming more conscious of the potential side effects of synthetic medications and are seeking alternative, natural solutions for their digestive issues. This trend is reflected in the growing popularity of herbal teas, supplements, and other natural remedies that are believed to aid digestion. Furthermore, there is an increasing demand for probiotic products, which are known to promote a healthy gut microbiome.

Local special circumstances:
Tunisia's healthcare system plays a significant role in shaping the Digestive & Intestinal Remedies market. The country has a well-established network of pharmacies, making these outlets the primary distribution channel for digestive and intestinal remedies. Pharmacies are easily accessible to consumers, and the presence of knowledgeable pharmacists allows for personalized recommendations and advice. This convenience and expertise contribute to the preference for purchasing these products from pharmacies rather than other retail channels.

Underlying macroeconomic factors:
Several macroeconomic factors have contributed to the growth of the Digestive & Intestinal Remedies market in Tunisia. Firstly, the country has witnessed an increase in disposable income, allowing consumers to spend more on healthcare products. This has led to a higher demand for remedies that address digestive issues. Additionally, Tunisia has experienced a rise in urbanization, leading to changing lifestyles and dietary habits. As people move away from traditional diets towards more processed and convenience foods, the incidence of digestive problems has increased, driving the demand for remedies. In conclusion, the Digestive & Intestinal Remedies market in Tunisia is growing due to increasing customer preferences for these products, driven by a growing awareness of digestive health and the adoption of Western dietary habits. The market is also influenced by the trend towards natural and herbal remedies, as well as the convenience and expertise offered by the country's pharmacy network. The underlying macroeconomic factors, such as rising disposable income and urbanization, further contribute to the market's growth. Overall, the outlook for the Digestive & Intestinal Remedies market in Tunisia remains positive, with opportunities for both local and international players in the industry.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)